Results 131 to 140 of about 4,214,353 (299)

Deep brain stimulation: current challenges and future directions

Nature Reviews Neurology, 2019
A. Lozano, N. Lipsman, H. Bergman, P. Brown, S. Chabardès, J. Chang, K. Matthews, C. McIntyre, T. Schlaepfer, M. Schulder, Y. Temel, J. Volkmann, J. Krauss   +12 more
semanticscholar   +1 more source

Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial [PDF]

, 2015
Nadia Kriek, George Groeneweg, DL Stronks, FJPM Huygen   +3 more
openalex   +1 more source

Depression treatment by tDCS-enhanced cognitive control training: A test of two stimulation intensities [PDF]

, 2021
Anja Sommer, Christian Plewnia
openalex   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS)

Clinical Neurophysiology, 2017
J. Lefaucheur, A. Antal, S. Ayache, D. Benninger, J. Brunelin, F. Cogiamanian, M. Cotelli, D. Ridder, R. Ferrucci, B. Langguth, P. Marangolo, V. Mylius, M. Nitsche, F. Padberg, U. Palm, E. Poulet, A. Priori, S. Rossi, M. Schecklmann, S. Vanneste, U. Ziemann, L. Garcia-Larrea, W. Paulus   +22 more
semanticscholar   +1 more source

Dengue Virus Directly Stimulates Polyclonal B Cell Activation

, 2015
Arturo Vargas Correa, Ana Carolina Egypto Rosa Berbel, Michelle Premazzi Papa, Ana Theresa Silveira de Morais, L M Peçanha, Luciana Barros de Arruda   +5 more
openalex   +2 more sources

Novel bifunctional cap for simultaneous electroencephalography and transcranial electrical stimulation [PDF]

, 2018
Sophia Wunder, Alexander Hunold, Patrique Fiedler, F. Schlegelmilch, Klaus Schellhorn, Jens Haueisen   +5 more
openalex   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

The role of electron-stimulated desorption in focused electron beam induced deposition [PDF]

, 2013
Willem F. van Dorp, Thomas W. Hansen, Jakob Birkedal Wagner, J. Th. M. De Hosson   +3 more
openalex   +1 more source